Carmell Therapeutics Statistics

Total Valuation

CTCX has a market cap or net worth of $45.19 million. The enterprise value is $45.84 million.

Market Cap	45.19M
Enterprise Value	45.84M

Important Dates

The last earnings date was Wednesday, May 15, 2024, after market close.

Earnings Date	May 15, 2024
Ex-Dividend Date	n/a

Share Statistics

CTCX has 20.73 million shares outstanding. The number of shares has increased by 1,941.39% in one year.

Shares Outstanding	20.73M
Shares Change (YoY)	+1,941.39%
Shares Change (QoQ)	+107.92%
Owned by Insiders (%)	33.77%
Owned by Institutions (%)	17.62%
Float	17.79M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.06
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.75

Current Ratio	0.75
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-24.90

Financial Efficiency

Return on equity (ROE) is -71.00% and return on invested capital (ROIC) is -810.55%.

Return on Equity (ROE)	-71.00%
Return on Assets (ROA)	-17.70%
Return on Capital (ROIC)	-810.55%
Revenue Per Employee	$2.44M
Profits Per Employee	-$852,585
Employee Count	9
Asset Turnover	0.51
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.92% in the last 52 weeks. The beta is 0.41, so CTCX's price volatility has been lower than the market average.

Beta (1Y)	0.41
52-Week Price Change	-79.92%
50-Day Moving Average	2.37
200-Day Moving Average	3.07
Relative Strength Index (RSI)	43.94
Average Volume (30 Days)	7,367

Short Selling Information

The latest short interest is 27,564, so 0.13% of the outstanding shares have been sold short.

Short Interest	27,564
Short Previous Month	23,525
Short % of Shares Out	0.13%
Short % of Float	0.15%
Short Ratio (days to cover)	3.99

Income Statement

In the last 12 months, CTCX had revenue of $21.92 million and -$7.67 million in losses. Loss per share was -$1.53.

Revenue	21.92M
Gross Profit	20.88M
Operating Income	-1.24M
Pretax Income	-7.94M
Net Income	-7.67M
EBITDA	-7.51M
EBIT	-7.63M
Loss Per Share	-$1.53

Full Income Statement

Balance Sheet

The company has $892,161 in cash and $1.54 million in debt, giving a net cash position of -$652,181 or -$0.03 per share.

Cash & Cash Equivalents	892,161
Total Debt	1.54M
Net Cash	-652,181
Net Cash Per Share	-$0.03
Equity / Book Value	-1.39M
Book Value Per Share	-0.07
Working Capital	-1.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.95 million and capital expenditures -$30,470, giving a free cash flow of -$8.98 million.

Operating Cash Flow	-8.95M
Capital Expenditures	-30,470
Free Cash Flow	-8.98M
FCF Per Share	-$0.39

Full Cash Flow Statement

Margins

Gross margin is 95.25%, with operating and profit margins of -5.65% and -35.01%.

Gross Margin	95.25%
Operating Margin	-5.65%
Pretax Margin	-36.20%
Profit Margin	-35.01%
EBITDA Margin	-34.24%
EBIT Margin	-34.80%
FCF Margin	-40.96%

Dividends & Yields

CTCX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,941.39%
Shareholder Yield	-1,941.39%
Earnings Yield	-16.98%
FCF Yield	-19.87%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CTCX has an Altman Z-Score of -11.27 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.27
Piotroski F-Score	4